Treating Alzheimer's Disease with X-ray Microbeams

New X-Ray Microbeam treatement for Alzheimer's Disease Background: Alzheimer's Disease is the the most common form of dementia among the elderly and affects over five million individuals in the United States. To date there is no definitive treatment to cure or halt the progression of Alzheimer's Disease. Approved pharmaco therapies offer only modest and transient symptomatic benefits. Technology Overview: The proposed x-ray method replaces conventional x-ray exposures used in pervious studies. This alternative is an efficient therapeutic outcome, one that is maintaining a tissue-sparing effect. Advantages: Treatment method is centered around maintaining a tissue-sparing effect allowing for 10X higher dose limits than conventional x-rays. Applications: Intellectual Property Summary: Provisional Patent Filed Stage of Development: Pre Clinical Licensing Potential: Licensing Status: Available for License Additional Information: Radiation therapy, X-Ray microbeams, Tissue-sparing effect, Computed tomography (CT) scanner, Profeinitor Glilal Cell, Cell Differentiation ,
Patent Information:
Technology/Start-up ID: